Tech Company Financing Transactions
Bone Biologics Funding Round
Bone Biologics, based in Burlington, secured $2 million from Hankey Capital.
Transaction Overview
Company Name
Announced On
5/7/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
We are pleased with the completion of this round of funding which will allow the company to continue process development leading to the manufacturing of Nell-1 in preparation for human clinical trials to validate the technology in regenerative medicine for bone.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2 Burlington Woods Dr. 100
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
Bone Biologics Corporation (OTCQB: BBLG) is a Biotechnology Company focused in the Orthobiologics space of regenerative medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Frelick
Chief Financial Officer
Deina Walsh
Chief Medical Officer
Scott Boden
Browse more venture capital transactions:
Prev: 5/7/2015: Trizic venture capital transaction
Next: 5/7/2015: HeyLets venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs